Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about InMed Pharmaceuticals Recent news which mentions InMed Pharmaceuticals EXCLUSIVE: New Alzheimer's Treatment? Promising Cannabinoid Compound Shows Hope, InMed CEO Says June 21, 2024 Tags cannabinoid Expert Ideas Alzheimer's disease From Benzinga Health Care, Biotech Leaders To Unveil Cutting-Edge Innovations June 17, 2024 Tags healthcare Benzinga Stories That Matter From Benzinga InMed Pharmaceuticals Has Multiple Milestones Coming Up In 2024, With A Focus On Three Conditions With An Unmet Need January 25, 2024 Tickers INM Tags InMed Pharmaceuticals Biotech Benzinga From Benzinga InMed's (NASDAQ: INM) Latest Research Demonstrates Potential In Treating Alzheimer's With A Rare Cannabinoid Analog December 11, 2023 Tickers INM Tags InMed Pharmaceuticals Biotech Benzinga From Benzinga InMed Pharmaceuticals, A Cannabinoid-Focused Company, Sponsored Benzinga's Cannabis Capital Conference October 16, 2023 Tickers INM Tags Markets INM Cannabis From Benzinga This Clinical Stage BioPharma Is Seeing Solid Growth In Rare Cannabinoid Demand From The Health And Wellness Sector September 15, 2023 Tickers INM Tags General Market News Cannabis From Benzinga Despite Global Economic Pressures, InMed Pharma's Accomplishments In 2022 Could Be A Catalyst For Further Growth In 2023 March 17, 2023 Tickers INM Tags Partner Content Market News INM From Benzinga This Company's Rare Cannabinoids May Hold Promise In The Treatment Of Neurodegenerative Diseases Like Alzheimer's January 11, 2023 Tickers INM Tags InMed Pharmaceuticals Penny Stocks Benzinga From Benzinga InMed Pharmaceuticals: The Clinical-Stage Company Setting Sites On Dominating Rare Cannabinoid Production And Commercialization Across Global Markets June 23, 2022 Tickers INM Tags Cannabis Market News Markets From Benzinga InMed Pharmaceuticals To Acquire BayMedica, Rare Cannabinoid Manufacturer, For ~$3.66M September 13, 2021 Tickers INM Tags General INM BayMedica From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.